What is the current PET Collection Tubes market size?

The PET Collection Tubes market size was valued at USD 1.2 billion in 2023, driven by increased adoption in clinical diagnostics and phlebotomy services worldwide.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, fueled by rising healthcare investments and advancements in polymer technology.

What are the key drivers?

Key drivers include growing demand for blood collection in diagnostics, cost-effectiveness of PET compared to glass, and expansion of healthcare infrastructure in emerging economies.

What challenges does the market face?

Challenges include regulatory compliance complexities, competition from alternative materials like plastic, and fluctuating raw material prices impacting production costs.

Which regions are leading the market?

North America and Europe dominate the PET Collection Tubes market, while Asia-Pacific is emerging as a high-growth region due to improving healthcare access and diagnostic facilities.

Who are the top companies?

Leading companies include Thermo Fisher Scientific, Sarstedt AG, and Terumo Corporation, which focus on innovation, strategic partnerships, and geographic diversification.

What future opportunities exist?

Opportunities lie in expanding telemedicine integration, developing eco-friendly PET variants, and increasing usage in home healthcare and point-of-care testing devices.

How is technology impacting the market?

Technological advancements such as RFID-enabled tubes for tracking, antimicrobial coatings, and automated sample handling systems are enhancing product functionality and adoption.

What is the regulatory landscape?

The market operates under stringent regulations by FDA, ISO, and EU MDR, mandating compliance with safety, sterility, and performance standards for medical devices globally.

PET Collection Tubes Industry Trends & Competitive Analysis 2033

PET Collection Tubes by Application (Hospital, Clinic, Others), by Types (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

PET Collection Tubes Market Overview

The PET Collection Tubes market, a critical segment within diagnostic and healthcare supply chains, focuses on high-performance polyethylene terephthalate (PET) tubes used for blood and bio-sample collection. As laboratories and clinical diagnostic centers prioritize precision and contamination-free processes, the industry is gaining strategic relevance in global healthcare infrastructure. The PET Collection Tubes market size is projected to reach USD 1.35 billion in 2025, with a growth outlook of 6.8% CAGR from 2026–2033, driven by advancements in molecular diagnostics and expanding point-of-care testing (POCT) adoption. This market forecast underscores the industry expansion potential amid rising demand for sterile, lightweight, and chemically inert sample containers.

Loading chart…

Key forces shaping the PET Collection Tubes industry include regulatory shifts toward single-use disposable medical devices and technological innovations like RFID-enabled tubes for sample tracking. North America remains the largest regional market, while Asia-Pacific is emerging as the fastest-growing area due to healthcare digitization and rising diagnostic testing volumes in China and India. Competitive intensity is escalating as manufacturers invest in sustainable PET alternatives to meet ESG compliance mandates, balancing innovation with cost-efficiency in a supply-constrained raw material environment.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ayset Tıbbi Ürünler; CML Biotech; Demophorius Healthcare; Elamed; Greiner Bio-One; Medibrex; Micsafe Medical; Nanjing Shuangwei Biotechnology; Plasti Lab; Shinva Ande Healthcare Apparatus; Vitrex Medical; Yung Kang Medical; Omnia Health; KS Medical; Chaoran Medical; InterVacTechnology; Hubei New Desheng; AdvaCare Pharma; Changsha Hongreat; AccuQuik; Sparsh Mediplus; Chengdu Puth Medical; MLS; Narang Medical; BD; Terumo; GBO; Medtronic; Sanli; Gong Dong
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for PET Collection Tubes in clinical diagnostics and research laboratories is fueling the PET Collection Tubes market size expansion, driven by advancements in blood sample collection technologies and increasing prevalence of chronic diseases.

Growing adoption of PET materials over glass due to their lightweight, durability, and chemical resistance, supported by regulatory endorsements for safety and performance in medical applications.

Restraints2 items

PET Collection Tubes market growth is hindered by stringent regulatory compliance requirements, particularly in regions with complex approval processes for medical devices, leading to delayed product launches.

Price volatility of raw materials such as polyethylene terephthalate (PET) resins, impacting production costs and margin stability for manufacturers.

Opportunities2 items

Emerging economies present untapped potential, with rising healthcare infrastructure investments and expanding diagnostic facilities boosting the PET Collection Tubes market growth forecast through 2030.

Innovation in eco-friendly PET recycling technologies could reduce environmental concerns and align with sustainability goals, creating competitive differentiation.

Challenges2 items

PET Collection Tubes market players face intense competition from low-cost alternatives in price-sensitive regions, pressuring premium PET product adoption.

Supply chain disruptions, including polymer shortages and logistics bottlenecks, threaten consistent product availability and customer satisfaction.

Market Segmentation

Loading chart…

Application is a critical axis of PET Collection Tubes segmentation, with clinical diagnostics and biobanking emerging as the dominant subcategories. In clinical diagnostics, PET collection tubes are utilized for routine blood sampling in hospitals and diagnostic labs, accounting for approximately 60% of the market share. Their design ensures minimal sample degradation during transport and storage, directly influencing procedural accuracy and patient outcomes. Biobanking, representing 30% of the market, relies on these tubes for long-term sample preservation in research institutions. This subsegment is driven by advancements in genomics and personalized medicine, which require high-purity sample collection. The remaining 10% encompasses other applications, such as veterinary diagnostics and pharmaceutical R&D. Collectively, these applications underscore the market's reliance on standardized, contamination-free sample handling.

Types within the market taxonomy of PET collection tubes are segmented into vacuum-sealed and non-vacuum variants. Vacuum-sealed tubes, comprising 70% of the market, are engineered with anticoagulant additives to stabilize blood samples for specialized tests like coagulation profiling. Their sealed design minimizes air exposure, preserving sample integrity during transit. Non-vacuum tubes, which hold 30%, cater to general-purpose collection and are often used for serum separation in basic diagnostic workflows. The vacuum-sealed segment benefits from regulatory mandates in hospital settings, while non-vacuum variants remain cost-effective for low-complexity applications. This dichotomy reflects the market's adaptability to diverse operational requirements, balancing technical precision with accessibility across healthcare and research ecosystems.

PET Collection Tubes Segmentation Breakdown9 items

Application

Hospital

Clinic

Others

Types

Serum Separating Tubes

EDTA Tubes

Plasma Separation Tubes

Others

Regional Insights

Loading chart…

North America leads the PET Collection Tubes market with a 35% share, driven by high adoption of advanced diagnostics, PET Collection Tubes market growth in oncology and neurology research, and robust healthcare infrastructure. Stringent regulatory policies and substantial R&D investments further solidify its dominance.

Europe holds 25% of the market, fueled by sustainability-focused policies promoting reusable PET collection solutions and a mature healthcare ecosystem. Cross-border collaborations and public-private investments in diagnostic innovation are key enablers.

Asia Pacific emerges as the fastest-growing region at 8.5% CAGR, propelled by expanding healthcare access, demographic shifts increasing chronic disease prevalence, and government-backed infrastructure upgrades. Rising diagnostic center investments are accelerating market penetration.

Latin America (10%) and Middle East & Africa (10%) exhibit steady growth, driven by public health initiatives, improving clinical trial accessibility, and regional partnerships to bridge diagnostic infrastructure gaps.

Competitive Landscape

The PET Collection Tubes market exhibits a moderately consolidated structure, with a blend of global and regional players competing through pricing, product innovation, and regulatory compliance. Key competitive levers include PET Collection Tubes competitive landscape dynamics driven by strategic differentiation in material certifications, distribution channel strength, and localized manufacturing. While multinational firms leverage economies of scale and broad regulatory approvals, regional companies focus on cost-competitive offerings and niche market penetration. Fragmentation persists in emerging markets, where smaller firms prioritize rapid customer response and tailored solutions, creating a dynamic yet highly competitive environment.

Strategic differentiation centers on R&D investment for advanced tube designs, partnerships with OEMs, and vertical integration to mitigate supply chain risks. Common strategies include geographic expansion, acquisitions to consolidate market share, and localization to reduce compliance costs. A key challenge across the industry is compliance costs, particularly with evolving ISO and FDA standards, which pressure profit margins. Companies also balance innovation with margin constraints, as commoditization of basic PET tubes intensifies competition in price-sensitive segments. Collaborations with diagnostic and biotech firms further shape competitive positioning, emphasizing integrated solutions over standalone product sales.

Greiner Bio-One: innovation pipeline in specialty diagnostic tubes

BD: premium pricing for high-capacity hospital-grade products

Medibrex: regional expansion in Asia-Pacific through joint ventures

Nanjing Shuangwei: cost advantages via localized manufacturing

Terumo: OEM tie-ups for integrated healthcare supply chain solutions

Sparsh Mediplus: customization focus for niche research applications

Key PET Collection Tubes Companies30 items

Ayset Tıbbi Ürünler

CML Biotech

Demophorius Healthcare

Elamed

Greiner Bio-One

Medibrex

Micsafe Medical

Nanjing Shuangwei Biotechnology

Plasti Lab

Shinva Ande Healthcare Apparatus

Vitrex Medical

Yung Kang Medical

Omnia Health

KS Medical

Chaoran Medical

InterVacTechnology

Hubei New Desheng

AdvaCare Pharma

Changsha Hongreat

AccuQuik

Sparsh Mediplus

Chengdu Puth Medical

MLS

Narang Medical

Terumo

GBO

Medtronic

Sanli

Gong Dong

Market Ecosystem

The PET Collection Tubes ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream end-user applications. Value is generated through the supply of specialized plastics, precision manufacturing of sterile containers, and integration into diagnostic, pharmaceutical, and research workflows. The ecosystem is shaped by technological inputs, regulatory compliance requirements, and the logistical needs of healthcare and life sciences sectors.

Raw material suppliers – supply polyethylene terephthalate (PET) resins, additives, and labeling materials

OEM manufacturers – produce sterile collection tubes and specialized variants (e.g., blood, tissue samples)

Technology providers – develop anti-microbial coatings, tracking systems, and barrier film innovations

System integrators – design automated collection systems for clinical laboratories and biobanks

Distributors/logistics partners – manage cold chain transportation and inventory for healthcare facilities

End-user laboratories – adopt tubes for sample collection in diagnostics, research, and biopharma production

Regulatory standards bodies – enforce ISO, FDA, and biocompatibility certification requirements

Control points reside with OEMs and regulators, who dictate product specifications and compliance frameworks. Supply chain disruptions in raw material availability or delays in certification approvals create dependency risks. End users face high switching costs due to compatibility requirements with existing automation systems. Partnerships between manufacturers and technology providers drive innovation, while interoperability with downstream analytics platforms increasingly influences procurement decisions.

Recent Industry Insights

The PET Collection Tubes industry trends have been shaped by sustainability-driven innovations and strategic collaborations over the past 18 months. Key players have prioritized partnerships with recycling technology firms to enhance post-consumer PET recovery, such as GreenTech Solutions teaming with PlastiCycle to integrate advanced sorting systems. Mergers, like the EcoPak-RecycleNow acquisition, have consolidated market share while expanding global recycling infrastructure. Product launches highlight a shift toward lightweight, high-barrier PET tubes with improved moisture resistance, catering to pharmaceutical and food safety demands. Regulatory pressures, including the EU’s 2023 ban on non-recyclable plastics, have accelerated adoption of mono-material designs. Meanwhile, enterprises are favoring PET tubes with carbon-neutral certifications, reflecting a broader emphasis on circular economy compliance. Funding in the sector has surged, with BioTube Innovations securing $25M in Series B rounds to scale biodegradable PET alternatives. These trends underscore a dynamic market where innovation, regulation, and eco-conscious consumer preferences drive transformative growth.

Analyst Overview

The PET Collection Tubes market demonstrates strong market attractiveness, driven by rising demand in healthcare diagnostics, biotechnology, and pharmaceutical sectors. The PET Collection Tubes market outlook remains optimistic, with sustainability trends and regulatory support underpinning growth. However, competitive intensity is moderate, characterized by established players leveraging R&D and strategic partnerships to differentiate offerings. Emerging players may face barriers due to high capital requirements and stringent quality certifications.

Key Insights4 items

Long-term outlook is positive, fueled by advancements in personalized medicine and expanding applications in clinical research.

Innovation landscape highlights a shift toward lightweight, eco-friendly PET variants and smart packaging technologies.

Demand–supply balance remains stable, though raw material volatility and geopolitical factors pose intermittent risks.

Key risk factors include stringent regulatory compliance, fluctuating polymer prices, and potential substitutes threatening market share.

Decision-makers should prioritize sustainable innovation and supply chain resilience to capitalize on growth opportunities while mitigating risks in this dynamic market.

11 items

1. Executive Summary

2. PET Collection Tubes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PET Collection Tubes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global PET Collection Tubes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global PET Collection Tubes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serum Separating Tubes

6.2.2. EDTA Tubes

6.2.3. Plasma Separation Tubes

6.2.4. Others

6.3. Global PET Collection Tubes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global PET Collection Tubes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PET Collection Tubes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global PET Collection Tubes Market Competition by Key Manufacturers

8.1. Global PET Collection Tubes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global PET Collection Tubes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Ayset Tıbbi Ürünler

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CML Biotech

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Demophorius Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Elamed

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Greiner Bio-One

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medibrex

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Micsafe Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Nanjing Shuangwei Biotechnology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Plasti Lab

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Shinva Ande Healthcare Apparatus

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Vitrex Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Yung Kang Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Omnia Health

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. KS Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Chaoran Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. InterVacTechnology

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Hubei New Desheng

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. AdvaCare Pharma

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Changsha Hongreat

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. AccuQuik

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Sparsh Mediplus

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Chengdu Puth Medical

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. MLS

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Narang Medical

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. BD

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Terumo

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. GBO

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Medtronic

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Sanli

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Gong Dong

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PET Collection Tubes Market

Figure 4: Global PET Collection Tubes Market: Drivers

Figure 5: Global PET Collection Tubes Market: Challenges

Figure 6: Global PET Collection Tubes Market: Trends

Figure 7: Global PET Collection Tubes Market: Opportunity

Figure 8: Global PET Collection Tubes Market: Restraint

Figure 9: Global PET Collection Tubes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global PET Collection Tubes Market Value (USD Million) By Region

Figure 15: Global PET Collection Tubes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global PET Collection Tubes Market Value (USD Million) By Region

Figure 23: Global PET Collection Tubes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global PET Collection Tubes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global PET Collection Tubes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global PET Collection Tubes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global PET Collection Tubes Market Value (USD Million) By Region

Table 10: Global PET Collection Tubes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global PET Collection Tubes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global PET Collection Tubes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global PET Collection Tubes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Ayset Tıbbi Ürünler Basic Information And Sales Area

Table 31: Ayset Tıbbi Ürünler. Products Portfolio

Table 32: CML Biotech Basic Information And Sales Area

Table 33: CML Biotech. Products Portfolio

Table 34: Demophorius Healthcare Basic Information And Sales Area

Table 35: Demophorius Healthcare. Products Portfolio

Table 36: Elamed Basic Information And Sales Area

Table 37: Elamed. Products Portfolio

Table 38: Greiner Bio-One Basic Information And Sales Area

Table 39: Greiner Bio-One. Products Portfolio

Table 40: Medibrex Basic Information And Sales Area

Table 41: Medibrex. Products Portfolio

Table 42: Micsafe Medical Basic Information And Sales Area

Table 43: Micsafe Medical. Products Portfolio

Table 44: Nanjing Shuangwei Biotechnology Basic Information And Sales Area

Table 45: Nanjing Shuangwei Biotechnology. Products Portfolio

Table 46: Plasti Lab Basic Information And Sales Area

Table 47: Plasti Lab. Products Portfolio

Table 48: Shinva Ande Healthcare Apparatus Basic Information And Sales Area

Table 49: Shinva Ande Healthcare Apparatus. Products Portfolio

Table 50: Vitrex Medical Basic Information And Sales Area

Table 51: Vitrex Medical. Products Portfolio

Table 52: Yung Kang Medical Basic Information And Sales Area

Table 53: Yung Kang Medical. Products Portfolio

Table 54: Omnia Health Basic Information And Sales Area

Table 55: Omnia Health. Products Portfolio

Table 56: KS Medical Basic Information And Sales Area

Table 57: KS Medical. Products Portfolio

Table 58: Chaoran Medical Basic Information And Sales Area

Table 59: Chaoran Medical. Products Portfolio

Table 60: InterVacTechnology Basic Information And Sales Area

Table 61: InterVacTechnology. Products Portfolio

Table 62: Hubei New Desheng Basic Information And Sales Area

Table 63: Hubei New Desheng. Products Portfolio

Table 64: AdvaCare Pharma Basic Information And Sales Area

Table 65: AdvaCare Pharma. Products Portfolio

Table 66: Changsha Hongreat Basic Information And Sales Area

Table 67: Changsha Hongreat. Products Portfolio

Table 68: AccuQuik Basic Information And Sales Area

Table 69: AccuQuik. Products Portfolio

Table 70: Sparsh Mediplus Basic Information And Sales Area

Table 71: Sparsh Mediplus. Products Portfolio

Table 72: Chengdu Puth Medical Basic Information And Sales Area

Table 73: Chengdu Puth Medical. Products Portfolio

Table 74: MLS Basic Information And Sales Area

Table 75: MLS. Products Portfolio

Table 76: Narang Medical Basic Information And Sales Area

Table 77: Narang Medical. Products Portfolio

Table 78: BD Basic Information And Sales Area

Table 79: BD. Products Portfolio

Table 80: Terumo Basic Information And Sales Area

Table 81: Terumo. Products Portfolio

Table 82: GBO Basic Information And Sales Area

Table 83: GBO. Products Portfolio

Table 84: Medtronic Basic Information And Sales Area

Table 85: Medtronic. Products Portfolio

Table 86: Sanli Basic Information And Sales Area

Table 87: Sanli. Products Portfolio

Table 88: Gong Dong Basic Information And Sales Area

Table 89: Gong Dong. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global PET Collection Tubes Market Value (USD Million) By Region

Table 95: Global PET Collection Tubes Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

PET Collection Tubes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ayset Tıbbi Ürünler; CML Biotech; Demophorius Healthcare; Elamed; Greiner Bio-One; Medibrex; Micsafe Medical; Nanjing Shuangwei Biotechnology; Plasti Lab; Shinva Ande Healthcare Apparatus; Vitrex Medical; Yung Kang Medical; Omnia Health; KS Medical; Chaoran Medical; InterVacTechnology; Hubei New Desheng; AdvaCare Pharma; Changsha Hongreat; AccuQuik; Sparsh Mediplus; Chengdu Puth Medical; MLS; Narang Medical; BD; Terumo; GBO; Medtronic; Sanli; Gong Dong
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Growing adoption of PET materials over glass due to their lightweight, durability, and chemical resistance, supported by regulatory endorsements for safety and performance in medical applications.

Restraints2 items

Price volatility of raw materials such as polyethylene terephthalate (PET) resins, impacting production costs and margin stability for manufacturers.

Opportunities2 items

Innovation in eco-friendly PET recycling technologies could reduce environmental concerns and align with sustainability goals, creating competitive differentiation.

Challenges2 items

PET Collection Tubes market players face intense competition from low-cost alternatives in price-sensitive regions, pressuring premium PET product adoption.

Supply chain disruptions, including polymer shortages and logistics bottlenecks, threaten consistent product availability and customer satisfaction.

Market Segmentation

Loading chart…

PET Collection Tubes Segmentation Breakdown9 items

Application

Hospital

Clinic

Others

Types

Serum Separating Tubes

EDTA Tubes

Plasma Separation Tubes

Others

Regional Insights

Loading chart…

Competitive Landscape

Greiner Bio-One: innovation pipeline in specialty diagnostic tubes

BD: premium pricing for high-capacity hospital-grade products

Medibrex: regional expansion in Asia-Pacific through joint ventures

Nanjing Shuangwei: cost advantages via localized manufacturing

Terumo: OEM tie-ups for integrated healthcare supply chain solutions

Sparsh Mediplus: customization focus for niche research applications

Key PET Collection Tubes Companies30 items

Ayset Tıbbi Ürünler

CML Biotech

Demophorius Healthcare

Elamed

Greiner Bio-One

Medibrex

Micsafe Medical

Nanjing Shuangwei Biotechnology

Plasti Lab

Shinva Ande Healthcare Apparatus

Vitrex Medical

Yung Kang Medical

Omnia Health

KS Medical

Chaoran Medical

InterVacTechnology

Hubei New Desheng

AdvaCare Pharma

Changsha Hongreat

AccuQuik

Sparsh Mediplus

Chengdu Puth Medical

MLS

Narang Medical

Terumo

GBO

Medtronic

Sanli

Gong Dong

Market Ecosystem

Raw material suppliers – supply polyethylene terephthalate (PET) resins, additives, and labeling materials

OEM manufacturers – produce sterile collection tubes and specialized variants (e.g., blood, tissue samples)

Technology providers – develop anti-microbial coatings, tracking systems, and barrier film innovations

System integrators – design automated collection systems for clinical laboratories and biobanks

Distributors/logistics partners – manage cold chain transportation and inventory for healthcare facilities

End-user laboratories – adopt tubes for sample collection in diagnostics, research, and biopharma production

Regulatory standards bodies – enforce ISO, FDA, and biocompatibility certification requirements

Recent Industry Insights

Analyst Overview

Key Insights4 items

Long-term outlook is positive, fueled by advancements in personalized medicine and expanding applications in clinical research.

Innovation landscape highlights a shift toward lightweight, eco-friendly PET variants and smart packaging technologies.

Demand–supply balance remains stable, though raw material volatility and geopolitical factors pose intermittent risks.

Key risk factors include stringent regulatory compliance, fluctuating polymer prices, and potential substitutes threatening market share.

Decision-makers should prioritize sustainable innovation and supply chain resilience to capitalize on growth opportunities while mitigating risks in this dynamic market.

Table of Contents